| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.071 | 0.08 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.29 | 0.08 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.09 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.09 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |